Kentucky bills · 2026 Regular Session
Kentucky HB 153
AN ACT relating to administrative regulations for medications for substance use disorder and declaring an emergency.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
No sponsor recorded.
Summary
Official abstract published by the Kentucky legislature· Summary of Original Version
Create a new section of KRS Chapter 13A to find 201 KAR 9:270 and 201 KAR 20:065 deficient and void; create new sections of KRS Chapters 311, 313, 314, and 315 to establish that the State Board of Medical Licensure, Board of Dentistry, Kentucky Board of Nursing, and Kentucky Board of Pharmacy shall not promulgate administrative regulations that restrict or limit the prescribing, dispensing, or administering of buprenorphine-mono-product, buprenorphine-combined-with-naloxone, or any other Schedule III, IV, or V medication approved by the United States Food and Drug Administration for the treatment of a substance use disorder; EMERGENCY.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 14, 2026 · House
to Health Services (H) - Jan 7, 2026 · House
to Committee on Committees (H) - Jan 7, 2026 · House
introduced in House